A Phase I Study of Farletuzumab, a Humanized Anti-Folate Receptor Α Monoclonal Antibody, in Patients With Solid Tumors
Investigational New Drugs - Netherlands
doi 10.1007/s10637-014-0180-8
Full Text
Open PDFAbstract
Available in full text
Date
November 9, 2014
Authors
Publisher
Springer Science and Business Media LLC